Eventide Asset Management, LLC Karuna Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $24.1 Million - $47.6 Million	-149,840 Reduced 44.09%	190,000 $60.1 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $21,076 - $27,914	-128 Reduced 0.04%	339,840 $57.5 Million
Q2 2023 Aug 15, 2023	BUY	$176.32 - $240.22 $12,342 - $16,815	70 Added 0.02%	339,968 $73.7 Million
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $29 Million - $36.7 Million	-179,802 Reduced 34.6%	339,898 $61.7 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $12.3 Million - $27.7 Million	-99,700 Reduced 16.1%	519,700 $117 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $12.1 Million - $18.4 Million	-128,600 Reduced 17.19%	619,400 $78.4 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $24 Million - $30.3 Million	-223,077 Reduced 22.97%	748,000 $85.3 Million
Q1 2021 May 14, 2021	BUY	$95.46 - $133.08 $6.68 Million - $9.32 Million	70,000 Added 7.77%	971,077 $117 Million
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $41.5 Million - $79.5 Million	686,234 Added 319.41%	901,077 $64.9 Million
Q4 2019 Jan 29, 2020	SELL	$11.44 - $123.99 $928,436 - $10.1 Million	-81,157 Reduced 27.42%	214,843 $16.2 Million
Q3 2019 Nov 21, 2019	SELL	$16.05 - $27.35 $13.5 Million - $23 Million	-840,234 Reduced 73.95%	296,000 $4.83 Million
Q2 2019 Aug 14, 2019	BUY	$20.02 - $20.02 $22.7 Million - $22.7 Million	1,136,234 New	1,136,234 $22.1 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.